Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study.
De Placido P, Pietroluongo E, De Angelis C, Tafuro M, Barraco C, Giannatiempo R, Buonaiuto R, Schettini F, Iervolino A, Vozzella EA, Giuliano M, Bianco R, Arpino G. De Placido P, et al. Among authors: giannatiempo r. Front Oncol. 2022 Aug 19;12:951026. doi: 10.3389/fonc.2022.951026. eCollection 2022. Front Oncol. 2022. PMID: 36059663 Free PMC article.
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
Zito Marino F, Buono S, Montella M, Giannatiempo R, Messina F, Casaretta G, Arpino G, Vita G, Fiorentino F, Insabato L, Sgambato A, Orditura M, Franco R, Accardo M. Zito Marino F, et al. Among authors: giannatiempo r. J Pathol Clin Res. 2023 Sep;9(5):367-377. doi: 10.1002/cjp2.324. Epub 2023 May 4. J Pathol Clin Res. 2023. PMID: 37143440 Free PMC article.
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies.
Miglietta F, Dieci MV, Giarratano T, Torri V, Giuliano M, Zustovich F, Mion M, Tondini CA, De Rossi C, Bria E, Franchi M, Merlini L, Giannatiempo R, Russo D, Fotia V, Poletti P, Caremoli ER, Arpino MG, De Salvo GL, Zambelli A, Guarneri V. Miglietta F, et al. Among authors: giannatiempo r. Eur J Cancer. 2023 Dec;195:113399. doi: 10.1016/j.ejca.2023.113399. Epub 2023 Oct 26. Eur J Cancer. 2023. PMID: 37950941 Free article.
Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients.
Crispo A, Augustin LSA, Luongo A, Calderaio C, Breda J, Coluccia S, Calabrese A, Marrazzo V, Giannatiempo R, Trasacco P, Palumbo E, Vitale S, Porciello G, Di Gennaro P, Caputo R, Buono G, Vernieri C, Schettini F, Grimaldi M, Nocerino F, Celentano E, Amore A, Giuliano M, De Placido P, De Angelis C, Bianco R, De Laurentiis M, La Vecchia C, Arpino G. Crispo A, et al. Among authors: giannatiempo r. Sci Rep. 2023 Dec 1;13(1):21208. doi: 10.1038/s41598-023-45439-y. Sci Rep. 2023. PMID: 38040773 Free PMC article.
Breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases.
Liguori G, Cantile M, Cerrone M, La Mantia E, Di Bonito M, Zanconati F, Curcio MP, Aquino G, La Mura A, Giannatiempo R, De Chiara A, Lombardi A, Botti G, D'Antonio A, Caraglia M, Franco R. Liguori G, et al. Among authors: giannatiempo r. Oncol Rep. 2012 Oct;28(4):1211-6. doi: 10.3892/or.2012.1942. Epub 2012 Jul 27. Oncol Rep. 2012. PMID: 22842723
Impact of Breast Tumor Onset on Blood Count, Carcinoembryonic Antigen, Cancer Antigen 15-3 and Lymphoid Subpopulations Supported by Automatic Classification Approach: A Pilot Study.
Baselice S, Castaldo R, Giannatiempo R, Casaretta G, Franzese M, Salvatore M, Mirabelli P. Baselice S, et al. Among authors: giannatiempo r. Cancer Control. 2021 Jan-Dec;28:10732748211048612. doi: 10.1177/10732748211048612. Cancer Control. 2021. PMID: 34620015 Free PMC article.
The New Paradigm of Network Medicine to Analyze Breast Cancer Phenotypes.
Grimaldi AM, Conte F, Pane K, Fiscon G, Mirabelli P, Baselice S, Giannatiempo R, Messina F, Franzese M, Salvatore M, Paci P, Incoronato M. Grimaldi AM, et al. Among authors: giannatiempo r. Int J Mol Sci. 2020 Sep 12;21(18):6690. doi: 10.3390/ijms21186690. Int J Mol Sci. 2020. PMID: 32932728 Free PMC article.
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
Orlandella FM, Mariniello RM, Mirabelli P, De Stefano AE, Iervolino PLC, Lasorsa VA, Capasso M, Giannatiempo R, Rongo M, Incoronato M, Messina F, Salvatore M, Soricelli A, Salvatore G. Orlandella FM, et al. Among authors: giannatiempo r. Br J Cancer. 2020 Aug;123(3):426-437. doi: 10.1038/s41416-020-0884-9. Epub 2020 May 18. Br J Cancer. 2020. PMID: 32418991 Free PMC article.
[Non-alcoholic steatohepatitis].
Vecchione R, Giannatiempo R, Fiorentino F, Terracciano L. Vecchione R, et al. Among authors: giannatiempo r. Pathologica. 2003 Oct;95(5):252. Pathologica. 2003. PMID: 14989001 Italian. No abstract available.
11 results